Navigation Links
Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting

s

Some of the statements in this press release are forward looking. Such statements are inherently subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Merck Serono S.A. and affiliates to be materially different from those expected or anticipated in the forward-looking statements. Forward-looking statements are based on Merck Serono’s current expectations and assumptions, which may be affected by a number of factors, including those discussed in this press release and more fully described in Serono’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission on February 28, 2006. These factors include any failure or delay in Merck Serono’s ability to develop new products, any failure to receive anticipated regulatory approvals, any problems in commercializing current products as a result of competition or other factors, our ability to obtain reimbursement coverage for our products, the outcome of any government investigations and litigation. Merck Serono is providing this information as of the date of this press release, and has no responsibility to update the forward-looking statements contained in this press release to reflect events or circumstances occurring after the date of this press release.

###

About Merck Serono S.A.

Merck Serono S.A. is a global biotechnology leader, with sales in over 90 countries. The Company is the world leader in reproductive health, with Gonal-f®, Luveris® and Ovidrel®/Ovitrelle®. It has strong market positions in neurology, with Rebif®, as well as in metabolism and growth, with Saizen®, Serostim® and Zorbtive™. The Company has recently entered the psoriasis area with Raptiva®. Merck Serono's research programs are focused on growing these businesses and on establishing new therapeutic areas
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:11/26/2014)... -- goBalto, Inc., the leading provider of cloud-based clinical study ... Red Herring,s Top 100 Global award. goBalto ... in 2013, marking its emergence as a top player ... Top 100 Global list has become a mark of ... Herring editors were among the first to recognize that ...
(Date:11/26/2014)... Nov. 25, 2014  Medtronic,s roughly $43 ... been widely discussed in the media for its ... a stronger leading player in one of the ... The healthcare market research firm said  the two ... a diverse set of solutions spanning inpatient to ...
(Date:11/26/2014)...   Heska Corporation (NASDAQ: HSKA ) ... of advanced veterinary diagnostic and other specialty veterinary products ... will attend The Benchmark Company, LLC,s Micro Cap Discovery Conference ... held at The Palmer House Hilton, 17 E. Monroe Street, ... 2:30 p.m. Please email hska@haydenir.com or contact your ...
Breaking Medicine Technology:goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Heska to Attend Benchmark Micro Cap Discovery Conference 2
... March 26, 2012  Tengion, Inc. (NASDAQ: TNGN ... it has made significant advances in its two lead ... several weeks in the ongoing initial clinical trial of ... Company also submitted a pre-Investigational New Drug (IND) filing ...
... 2012 Beginning today, Northside Hospital and Atlanta Perinatal ... advanced screening test for common fetal trisomies, such as ... that causes Edwards syndrome. The Harmony ... a novel testing platform to analyze DNA in maternal ...
Cached Medicine Technology:Tengion Announces Significant Advances in Neo-Urinary Conduit™ and Neo-Kidney Augment™ Programs 2Tengion Announces Significant Advances in Neo-Urinary Conduit™ and Neo-Kidney Augment™ Programs 3Tengion Announces Significant Advances in Neo-Urinary Conduit™ and Neo-Kidney Augment™ Programs 4Tengion Announces Significant Advances in Neo-Urinary Conduit™ and Neo-Kidney Augment™ Programs 5Tengion Announces Significant Advances in Neo-Urinary Conduit™ and Neo-Kidney Augment™ Programs 6Northside Hospital and Atlanta Perinatal Consultants Partner to Offer Advanced, Non-Invasive Test for Prenatal Detection of Common Trisomies 2Northside Hospital and Atlanta Perinatal Consultants Partner to Offer Advanced, Non-Invasive Test for Prenatal Detection of Common Trisomies 3
(Date:11/26/2014)... November 26, 2014 The Maryland ... for the tenth annual MEDA Awards, which, sponsored ... excellence in Maryland. “The MEDA Awards recognize the ... to the state. We encourage our members to ... making a positive economic impact in the state ...
(Date:11/26/2014)... The American Anthropological Association (AAA) has ... of meetings and conferences. Suvarnakar will be responsible ... and conferences. , “I am pleased to ... Executive Director Ed Liebow. “She brings the Association ... was recognized in January as the 2013 Professional ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Loffler Companies ... The Week in Imaging, an online information and news ... This is the sixth consecutive year Loffler has earned ... years. , The Elite Dealer Awards honor the best ... This year’s Elite Dealer honorees were chosen for their ...
(Date:11/26/2014)... Sonru, the video interviewing specialist, has today announced ... Chief Marketing Officer, in addition to the formal opening ... has been appointed as Chief Operating Officer. He is ... Chief Marketing Officer. , Mr Jones is a seasoned ... senior roles with The Walt Disney Company and Adventis ...
(Date:11/26/2014)... Bunion Bootie, the newest and best ... early celebration of the early holiday shopping season. Starting ... the promotional price of $29.95 each (normally $33.95 ea). ... any automatic discounts applied when buying more than one ... for complete details. It’s simple: purchasing more Bunion Booties ...
Breaking Medicine News(10 mins):Health News:Maryland Economic Development Association Seeking Submissions for 2015 Awards 2Health News:American Anthropological Association Appoints New Director of Meetings and Conferences: Ushma Suvarnakar 2Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2
... with expansion of Ascension,s product line and ... distribution ... medical device company that develops, manufactures and markets,joint replacement, trauma and ... today that it has secured $21,million in a Series D financing. ...
... zones based on structure may help cosmetic surgeons perform ... effects, according to a report in the January issue ... JAMA/Archives journals. , The lips are an essential ... information in the article. Studies have found that wider ...
... finds fresh suspects for autoimmune disease , , MONDAY, Jan. ... have pinpointed a batch of genes that can trigger ... a clear-cut diagnosis and a cure for decades. , ... Dr. Noel Rose, who is director of the Johns ...
... Colo., Jan. 21 The American College ... an extensive,update to its evidence-based practice guidelines. ... latest revision to ACOEM,s Occupational Medicine Practice,Guidelines: ... and,Functional Recovery in Workers, 2nd Ed., currently ...
... "As America marks the,35th anniversary of the Roe ... our nation, pro-life advocates in 59 cities across 31 ... unique nationwide pro-life,campaign, 40 Days for Life," said David ... February 6 until March 14, people across,America will join ...
... Jan. 21 American Media, Inc. (AMI) today,announced ... President and,Chief Financial Officer of American Media Operations, ... with more than 30 years of,financial and publishing ... serve as a consultant to the company., ...
Cached Medicine News:Health News:Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO 2Health News:Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO 3Health News:Dividing lip zones to be injected for augmentation may help increase patient satisfaction 2Health News:New Batch of Lupus Genes Discovered 2Health News:New Batch of Lupus Genes Discovered 3Health News:Low Back Disorders Chapter Released 2Health News:Abortion Opponents in 59 Cities Prepare Focused 40-Day Campaign to Counter Impact of Roe v. Wade 2Health News:American Media, Inc. Names Dean Durbin Executive Vice President and Chief Financial Officer 2Health News:American Media, Inc. Names Dean Durbin Executive Vice President and Chief Financial Officer 3
... Healthcares Timeter® PCS 414 portable air compressor is ... you may wonder if its running. Youll like ... durable, mar-resistant steel case thats easy to clean ... pounds. The PCS 414 has been engineered for ...
... Compact sporty design and powerful ... the product of choice for ... performance. The CompAir XL features ... storage compartment and a handy ...
Portable Compressor Nebulizer...
The AeroMax nebulizer compressor features convenient storage space for medications and accessories. Aluminum compressor components ensure a long, trouble-free life and consistent performance. Rx ONLY...
Medicine Products: